Maghinay, Imelda D.
HRN: 27-88-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2026
CEFUROXIME 1.5GM (VIAL)
02/26/2026
02/26/2026
IV
1.5g
Single Dose
Preop
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: